glp-1 weight loss drug news today october 2025 California Ends Medicaid Coverage of Drugs Despite TrumpRx Plan New research shows that while

GLP-1 medications start with low doses that gradually increase over weeks, meaning the full appetite-suppressing effect takes longer to develop

Diabetes Obes Metab 22(12):24872492 [DOI] [PMC free article] [PubMed] [Google Scholar] Verma S, Bhatta M, Davies M, Deanfield JE, Garvey WT, Jensen C, et al (2023) Effects of once-weekly semaglutide 2.4 mg on C-reactive protein in adults with overweight or obesity (STEP 1, 2, and 3): Exploratory analyses of three randomised, double-blind, placebo-controlled, phase 3 trials

1 CVS says the change is intended to improve affordability and expand treatment options for employers offering GLP-1 coverage

Jensen VM, Rasmussen AW

Niazi explains its a naturally occurring hormone that regulates metabolism (how the body uses energy)

Sue Decotiis, a New York City-based board-certified weight-loss physician, noted that many of the reported symptoms, such as disorientation and fatigue, are most likely due to dehydration and hypoglycemia (low blood sugar)